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modify steps in the partner services algorithm tested 
in this study to improve effi  ciency. In the meantime, 
application of the partner services algorithm as tested 
in this study seems to pose little risk because the new 
approach resulted in an almost 15 times increase in new 
testing and fi ve times increase in new diagnoses. With 
eff ect sizes this large, a very large unknown confounder 
would have to be present in the environment for the 
fi ndings not to be valid. Despite achievements to date 
and known barriers that have prevented adoption 
of partner services, fi ndings from this study support 
calls to say no to complacency made during the AIDS 
2016 conference in Durban.9 Scaling up of immediate 
assisted partner services is clearly an innovative case-
fi nding approach that might be instrumental in helping 
countries achieve UNAIDS Fast-Track Targets by 2030.10
Some issues pertinent to sustainability exist. For 
example, the authors note counsellors’ training 
requirements and suggest that some eff orts might 
be needed to rely on “task shifting to a less highly 
educated cadre than those used in this study” in the 
future. Additionally, districts with administrative 
hurdles or low numbers of people with HIV infections 
were excluded from the trial. A national programme 
would of course have to overcome these hurdles and 
provide a minimum level of services for low-prevalence 
sites. That noted, the study incorporated 18 of 28 
districts across Kenya with a-priori administrative 
acceptance, indicating fi rst steps toward sustainability.
In the USA, HIV partner services appear to be a cost-
eff ective prevention and control strategy.11 In countries 
such as many of those in sub-Saharan Africa, even 
though the cost of treatment might be lower than in 
the USA, and therefore cost-eff ectiveness harder to 
achieve, the number of undiagnosed HIV cases in sub-
Saharan Africa suggests that any method that yields as 
many cases as shown in this study is likely to be worth 
the investment. For that matter, a partner services 
programme also reveals networks of transmission and 
social contact and connects people infected with HIV 
to life-saving health services. A well known comment in 
partner services literature reads “contact tracing’s price 
is not its value”,12 an axiom shown once again. 
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Assessing progress with HIV incidence in national cohorts
In The Lancet HIV, Jessica Justman and colleagues1 
provide HIV incidence rates for Swaziland from 
a national 6 month follow-up study, making an 
important contribution to understanding the dynamics 
of the HIV epidemic in this small southern African 
country with a population of 1·25 million people. 
145 HIV seroconversions were observed in a cohort of 
11 232 HIV-negative individuals during 6086 person-
years of observation, leading to an HIV incidence rate 
of 2·4 per 100 person-years. 
At the national-level, reliable estimates of both 
prevalence and incidence are required to appreciate 
the changing dynamics of HIV infection. Although 
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available, accurate data for incidence are scarce. Very 
few prospectively measured HIV incidence rates are 
available, beyond HIV prevention trials, at the district, 
national, or regional level. Instead, mathematical 
models or laboratory assays for recent infection are 
most often used to calculate HIV incidence on the basis 
of data or samples from one or more seroprevalence 
surveys. 
Although useful, estimates from mathematical models 
should be interpreted with care as their results can vary 
substantially depending on both the structure of the 
model and assumptions involved. Several laboratory 
techniques, including the assay for p24 antigen in the 
absence of antibodies, the BED-CEIA assay (a capture 
enzyme immunoassay with gp41 peptides from HIV 
subtypes B, E, and D), and more recently, nucleic acid 
amplifi cation in the absence of antibodies, can identify 
those recently infected to estimate HIV incidence. Even 
though the accuracy of tests has improved over the past 
decade, the variability in each test2 makes extrapolation 
dependent on what constitutes recent for each assay. 
Swaziland’s closest neighbours have national HIV 
incidence estimates as determined with BED-CEIA 
assays (South Africa3 and Botswana4) or mathematical 
models (Zimbabwe5 and Mozambique6); none have 
cohort-based national HIV incidence measures. So, are 
national-based cohort studies to measure HIV incidence 
required? 
Given that the UN has adopted the goal of ending AIDS 
as a global health threat by 2030,7 accurate estimates 
of HIV incidence over time will be needed to assess 
progress towards the attainment of this goal. To assess 
changes in HIV incidence, individual measures will need 
to be reliable, with narrow confi dence intervals. Such 
measures of HIV incidence are going to become a key 
marker for assessing country-level HIV epidemic trends. 
Accurate measurements of incidence are also needed to 
measure the eff ectiveness of prevention interventions, 
either singly or in combination. Although cohort-based 
HIV incidence is routinely measured in randomised 
controlled trials assessing HIV prevention modalities, it 
is rarely used to assess the eff ect of national prevention 
programmes. 
The main reason for the dearth of national, cohort-
based HIV incidence measurements is that large cohorts 
need to be followed for long periods to get reliable 
estimates, making measurement of HIV incidence time 
consuming, expensive, and logistically and ethically 
diffi  cult.8 A further limitation of cohort studies is that 
their provision of safer sex interventions such as HIV 
counselling, condom promotion, sexually transmitted 
infection treatment and other HIV prevention 
interventions might change the HIV risk behaviour of 
participants. Individuals might also modify their risk 
taking behaviour in response to their awareness of 
being observed, the so-called Hawthorne eff ect.9 As a 
result, there are concerns that measuring HIV incidence 
through identifying seroconversions during long-term 
follow-up might not produce accurate estimates of the 
HIV incidence. 
Despite these limitations, the measurement of HIV 
seroconversions during follow-up is the gold standard 
for HIV incidence. Without cohort-based estimates, 
country-level progress toward the UN 2030 goal will be 
diffi  cult to assess. As HIV incidence usually declines in 
small decrements, extrapolations from mathematical 
models or laboratory assays might not identify these 
changes because of the inherent variability in their 
estimates. Although multilevel sampling strategies are 
well established to provide reasonably representative 
samples, large studies will be required for cohort-
based approaches to detect small changes in HIV 
incidence over time. In Swaziland, which is smaller than 
many cities, it was practically feasible to establish a 
national cohort to assess a national male circumcision 
intervention.1 This might be a much more complex task 
in larger countries.
Swaziland is the fi rst country in southern Africa 
to have a national cohort-based HIV incidence rate, 
serving as an example to encourage others to follow 
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on a new level of importance for measuring the eff ect 
of population-level interventions and monitoring 
progress on the path to HIV epidemic control. 
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